$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Carter Worth likes 'Dogs of the Dow' Amgen and Cisco
02:22pm, Tuesday, 27'th Dec 2022
Carter Worth, Worth Charting founder and CIO, joins 'The Exchange' to discuss buying the 'Dogs of the Dow.'
2 Market-Beating Stocks to Buy in 2023 and Hold Forever
11:00am, Saturday, 24'th Dec 2022
For these companies' shareholders, it may be tempting to take profits right now. But both stocks can keep growing for a while.
Jefferies Makes Massive 2023 Changes to ‘Strong Buy' Franchise List of Top Stock Picks
07:23am, Thursday, 22'nd Dec 2022
All the companies that we follow here at 24/7 Wall St. keep a curated list for their institutional and high net worth retail clients of their highest conviction stock picks.
Amgen Stock: How Has The Acquisition News Moved AMGN Shares Since The Announcement?
09:33am, Wednesday, 21'st Dec 2022
Amgen announced that it is buying Horizon Therapeutics for more than $26 billion. Here is what the deal means for Amgen's business moving forward and for investors.
Amgen (AMGN) Stock Moves -0.64%: What You Should Know
10:50pm, Monday, 19'th Dec 2022 Zacks Investment Research
In the latest trading session, Amgen (AMGN) closed at $265.70, marking a -0.64% move from the previous day.
Building A $100,000 Market-Crushing Dividend Portfolio
12:30pm, Monday, 19'th Dec 2022 Seeking Alpha
In this article, I start by explaining the theoretical background behind the success of dividend (growth) investing. Read more here.
Amgen Is Making A Smart Move With Horizon Therapeutics
09:55am, Monday, 19'th Dec 2022
Amgen is making a major acquisition of Horizon Therapeutics, one that it can comfortably afford. The biopharmaceutical business is incredibly expensive and risky, there's no guarantee this pans out fo
The 7 Best Retirement Stocks to Buy Now
04:34pm, Sunday, 18'th Dec 2022
The best retirement stocks are easy enough to find if you take the time to look. While it still is a challenging time to invest if you have a short time horizon, for investors with longer time horizon
Wall Street Breakfast: What Moved Markets
01:20pm, Saturday, 17'th Dec 2022 Seeking Alpha
Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.
2 Best Biotech Stocks to Buy Right Now
02:00pm, Friday, 16'th Dec 2022 The Motley Fool
Demand for medicines and vaccines has nowhere to go but up over the long run.
Gilead: Downgrade To Hold
09:29am, Friday, 16'th Dec 2022 Seeking Alpha
Gilead's return profile has weakened substantially given the valuation risks and fundamental uncertainties. Read why GILD is a Hold.
Cytokinetics (CYTK) Up Despite Unfavorable FDA Committee Voting
03:12pm, Thursday, 15'th Dec 2022 Zacks Investment Research
Cytokinetics (CYTK) gets an unfavorable recommendation from CRDAC on omecamtiv mecarbil for the treatment of heart failure with reduced ejection fraction.
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
02:00pm, Thursday, 15'th Dec 2022 Zacks Investment Research
Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The Best ETF For Dividend Yield And Dividend Growth
12:47pm, Thursday, 15'th Dec 2022 The Motley Fool
This ETF checks off all the boxes in terms of performance, dividend growth, and solid yield.
5 Stocks to Watch on Dividend Hikes Before 2022 Wraps Up
12:34pm, Thursday, 15'th Dec 2022 Zacks Investment Research
Investors may keep a tab on LW, NUE, PWRr, TTC, and AMGN which have lately hiked their dividend payments to reward investors.
Sign In
Buy AMGN